Form 4: Edwards Lifesciences Executive Reports Stock Transaction
Insider Transaction (Form 4)
Andrew M. Dahl, SVP, Corporate Controller of Edwards Lifesciences Corp, reported a transaction in 253 shares of common stock on September 13, 2026.
Summary
- Tax/exercise-price withholding: disposed of 253 Common Stock at $84.37 ($21,346) on September 13, 2026; holds 14,615 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Andrew M. Dahl — Officer (SVP, Corporate Controller)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-13 | Tax/exercise-price withholding | Common Stock | 253 | $84 | $21.3K | 14,615.41 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-13 | Tax/exercise-price withholding (253 shares) |
Keywords
insider transaction, Form 4, EW, Edwards Lifesciences Corp, neutral, Andrew M. Dahl
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.